Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
MOREPENLAB Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Low Debt to Equity, not much change from last year
Negative
Weak price momentum
Low and declining ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
MOREPENLAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
MOREPENLAB Bulk, Block & Insider Trades
MOREPENLAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Rights issue
Stock split
Others
Rights issue(1 new shares @ 100 INR for 1 existing shares) Ex-date: 4th Sep 1996 Announced on: 12th Apr 1996
Stock split(1 : 5)Nominal value change from Rs 10 to Rs 2. Ex-date: 6th Nov 2000 Announced on: 6th Nov 2000
Non-renounceable rights issue in different stockRights issue of 0% FCDS of INR 100. Each debenture is convertible into 2 equity shares of INR 10 each at INR 50 per share on 12 months expiry from allotment. Ex-date: 11th Feb 1994
Company Profile
Morepen Laboratories Limited is a pharmaceutical company. The Company is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also home health products. Its APIs include Apixaban, Edoxaban, Lin... Read More
Key personnel
Mr. Sushil SuriD
Executive Chairman of the Board, Managing Director
Mr. Ajay Kumar Sharma
Chief Financial Officer
Mr. Vipul Kumar Srivatava
Compliance Officer, Company Secretary
Mr. Sanjay SuriD
Whole-Time Director
Mr. Sharad JainD
Independent Director
Mr. Ranjit KhattarD
Independent Director
Mrs. (Dr.) SavitaD
Non-Executive Independent Director
Mr. Praveen Kumar DuttD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Morepen Laboratories Ltd.?
The current share price of Morepen Laboratories Ltd. is ₹ 39.12 as of 09 Jan 2026.
What is the PE ratio of Morepen Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Morepen Laboratories Ltd. is 21.73 as of the latest financial data.
What is the ROE and ROCE of Morepen Laboratories Ltd.?
Morepen Laboratories Ltd. has a Return on Equity (ROE) of 8.55% and a Return on Capital Employed (ROCE) of 9.15% as per the latest financial reports.
What is the market cap of Morepen Laboratories Ltd.?
The market capitalization of Morepen Laboratories Ltd. stands at ₹ 2,143.60 Cr.
What is the dividend yield of Morepen Laboratories Ltd.?
The dividend yield of Morepen Laboratories Ltd. is 0.51% based on the current market price.
What is the RSI of Morepen Laboratories Ltd.?
The Relative Strength Index (RSI) of Morepen Laboratories Ltd. is 35.86.
What is the FII and DII holding in Morepen Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 1.62% and Domestic Institutional Investors (DII) hold 1.49% of Morepen Laboratories Ltd. shares.
What sector does Morepen Laboratories Ltd. belong to?
Morepen Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Morepen Laboratories Ltd. stock?
The beta of Morepen Laboratories Ltd. stock is 1.95, indicating its volatility relative to the broader market.
